Log in or Sign up for Free to view tailored content for your specialty!
Cardiometabolic Disorders News
Promising new drugs usher in ‘transformational time’ for obesity treatment
A new generation of obesity drugs is changing the treatment landscape for patients and providers, with options that can lead to weight loss unheard of just a few years ago.
Canagliflozin mediates biomarkers prognostic of cardiorenal risk in diabetes, albuminuria
Blood tests showed that canagliflozin plus standard care lowered biomarkers levels associated with chronic kidney disease and CVD events in patients with diabetes and albuminuria vs. placebo, researchers reported.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Infertility can indicate future cardiometabolic conditions in women
DANA POINT, Calif. — In this Healio video exclusive, an expert discusses the links between infertility and adverse cardiometabolic health in women.
Smoking, little physical activity increase risk for lower limb amputations in diabetes
Adults with diabetes who smoke or exercise less than once per week are among those at higher risk for a lower limb amputation, but adults with obesity may have a lower risk for amputations, according to study data.
‘Recharge, learn and engage’ at CMHC Women’s Cardiometabolic Health and Wellness Masterclass
A wellness-inspired 4-day masterclass covering all aspects of women’s cardiometabolic health offers attendees a mix of multidisciplinary education, networking activities and professional development, as well as ways to relax and recharge.
Growth hormone lowers liver fat for adults with obesity, steatotic liver disease
Adults with overweight or obesity and metabolic dysfunction-associated steatotic liver disease had a more than 5% reduction in liver fat at 6 months with growth hormone therapy, according to findings from a randomized controlled trial.
Patients with diabetes, worsening HF benefit from sotagliflozin at or before discharge
In a post hoc analysis of SOLOIST-WHF, patients with type 2 diabetes hospitalized for worsening HF had lower rates of CV death and HF rehospitalization if they received sotagliflozin on or before discharge than if they did not.
Study links TV viewing in childhood to metabolic syndrome as adult
A long-running cohort study found an association between frequent television viewing as a child and developing metabolic syndrome as an adult, according to results reported in Pediatrics.
Topline data show semaglutide cuts CV risk by 20%: SELECT
Compared with placebo, injectable semaglutide 2.4 mg reduced risk for major adverse CV events by 20% for people with overweight or obesity and established CVD, according to topline data from the SELECT study.
Healio partners with CMHC for annual congress
Together with Healio, Cardiometabolic Health Congress will welcome providers across many medical specialties to learn from pioneers and visionaries in the cardiometabolic health movement this fall.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read